Get your daughters off the couch: New research shows exercise during the teen years -- starting as young as age 12 -- can help protect girls from breast cancer when they're grown
New research shows exercise during the teen years -- starting as young as age 12 -- can help protect girls from breast cancer when they are grown.
Why do some smokers get cancer and others don't? Scientists have discovered two genetic variants that may be the reason
Daphne Babrow's son, Evan, is only 5 months old and she's already thinking about getting pregnant again. The decision won't be easy.
A recent green light from regulators could mean a brighter outlook from Genentech when the biotech meets with analysts Friday.
Gray goo or the future of medicine? CNN spoke to Naomi Halas, a professor at Rice University in Texas, about nanotechnology and her work on nanoshells, tiny particles that may hold the key to curing cancer.
Let's face it: There's no body part women obsess about more than breasts -- their size, shape, sag factor, and whether those strange pains stem from monthly PMS hormones or something more ominous, like breast cancer.
Nikki Caldwell's got 10 weeks to sell Pat Summitt on the sidecar.
U.S. cancer deaths rose by more than 5,000 in 2005, a somewhat disappointing reversal of a two-year downward trend, the American Cancer Society reported
Roy Scheider, a two-time Oscar nominee who played the alarmist police chief who famously saves a beach resort in the 1975 blockbuster Jaws and its sequel, died Sunday. He was 75.
Get your daughters off the couch: New research shows exercise during the teen years -- starting as young as age 12 -- can help protect girls from breast cancer when they're grown
New research shows exercise during the teen years -- starting as young as age 12 -- can help protect girls from breast cancer when they are grown.
Why do some smokers get cancer and others don't? Scientists have discovered two genetic variants that may be the reason
Daphne Babrow's son, Evan, is only 5 months old and she's already thinking about getting pregnant again. The decision won't be easy.
A recent green light from regulators could mean a brighter outlook from Genentech when the biotech meets with analysts Friday.
Gray goo or the future of medicine? CNN spoke to Naomi Halas, a professor at Rice University in Texas, about nanotechnology and her work on nanoshells, tiny particles that may hold the key to curing cancer.
Let's face it: There's no body part women obsess about more than breasts -- their size, shape, sag factor, and whether those strange pains stem from monthly PMS hormones or something more ominous, like breast cancer.
Nikki Caldwell's got 10 weeks to sell Pat Summitt on the sidecar.
U.S. cancer deaths rose by more than 5,000 in 2005, a somewhat disappointing reversal of a two-year downward trend, the American Cancer Society reported
Roy Scheider, a two-time Oscar nominee who played the alarmist police chief who famously saves a beach resort in the 1975 blockbuster Jaws and its sequel, died Sunday. He was 75.
A new report says your baby's bottle may leach a potentially toxic chemical. Should consumers do something about it?
Not every mother would allow her hair to be cut by her 4-year-old daughter, but Cindy Hurst thought it was a perfect idea.
With no work on Wisteria Lane these days (thanks to the Hollywood writers' strike), Desperate Housewives's Marcia Cross put her free time to use this week, lobbying Congress to pass 12-year-old legislation for breast cancer patients.
Scientists have traced a genetic mutation that causes a hereditary form of colon cancer back to a single couple who left England for America in the 1630s
Common genetic variants raise a man's risk of prostate cancer -- especially in combination with family history
Genentech, the word's largest biotech in terms of market capitalization, reported a healthy increase in sales and earnings for the fourth quarter.
Here is a list of the 61 cancer centers in the United States and links to their Web sites:
A new study shows that this once-popular breast-cancer therapy proves ineffective
So you're scared of breast cancer. Smart lady. Nearly 200,000 women will learn they have breast cancer this year, and you don't want to be one of them. You're doing everything you can to make sure you're not next -- doing breast exams, getting mammograms -- but you think it would be great if you could get a test to see if you'll develop breast cancer.
Genentech scientists won't waste any time fretting the FDA panel decision to reject Avastin as a breast cancer treatment. The reason: The biotech giant has at least three clinical breast cancer trials underway - at least one of which is likely to succeed.
A panel of FDA advisors did not support the use of Genentech's Avastin as a breast cancer drug.
Genentech Inc. faces a high-stakes decision by a government panel Wednesday over the cancer drug Avastin.
Cathy Bueti was widowed at the age of 25 when her husband was killed in a car accident. Seven years later, she says, "I finally started to feel like my life was coming back together, then I found the lump."
In discussions about breast cancer, the male form of the disease is often overlooked -- so, men end up going longer without diagnosis or treatment
New research shows the adage "what doesn't kill us makes us stronger" doesn't apply in treating breast cancer.
Actress Jaclyn Smith will never forget the day she found out she had breast cancer. And she'll never forget the lesson she learned in those very first moments of being a cancer patient.
Genentech reported a surge in third-quarter earnings that barely beat Wall Street projections, while its revenue increase fell just short of estimates.
A small California drug company hopes to extract the next cancer cure from Chinese herbs
Two studies show that chemotherapy doesn't work equally well for all cancers, raising hopes of tailoring the treatment
Which prostate cancer treatment is right for you? A new study suggests surgery may increase your chances of survival
We've heard for nearly a decade about the benefits of alcohol -- red wine in particular. It's good for your heart and may have other positive effects. In moderation, we thought, it's not only OK, but actually good for us.
Bristol-Myers Squibb faces a moment of truth this month when the FDA decides whether its experimental chemotherapy for breast cancer is good enough for the U.S. market.
Merck's cervical cancer vaccine Gardasil now faces direct competition from Glaxo's Cervarix, which was approved by European health authorities, said the vaccine's maker GlaxoSmithKline on Monday.
The American Cancer Society is devoting its entire $15 million advertising budget for 2007 to highlight the problems faced by Americans who don't have any or enough health insurance.
China has recalled two tainted leukemia drugs tied to "adverse reactions" in patients, the state-run Xinhua news agency reported Sunday.
ImClone stock fell Friday after an analyst downgraded the biotech, based on his conversation with doctors who were hesitant to use Erbitux as a lung cancer drug.
Edward Gramlich, a former member of the Federal Reserve board who raised warnings about the housing boom, died Wednesday of leukemia. He was 68.
Thousands more lung cancer patients each year could be offered surgery or other aggressive therapy under a new system that classifies many tumors as more treatable than in the past.
The FDA has approved the vaccine only for girls and women up to age 26. Now a medical debate is raging over whether older women should get it too
A large study from Europe suggests it doesn't hurt to wait a few years between prostate cancer screenings -- but the research won't end debate over the value of PSA tests.
Invasive breast cancer rates have fallen since the substantial decline in postmenopausal hormone replacement therapy occurred, even after a decline in breast cancer screening rates, according to findings published in the 5th Journal of the National Cancer Institute.
TThe drug helps protect teenage girls from the virus that can cause cervical cancer, but a new study shows it does little to help women who already are already infected
Eli Lilly & Co.'s osteoporosis drug Evista reduces the risk of breast cancer in some patients, but at a cost of an increased risk of serious side effects, regulatory reviewers said in documents released Friday.
Breast cancer survivors who ate more fruits and vegetables were not more likely to avoid a cancer recurrence
The FDA says no to labeling tomato products as anti-cancer foods. But that's no reason to cut the veggie from your diet
The French government has agreed to subsidize a cervical cancer vaccine made by Merck for teenage girls and young women, according to Merck's marketing partner, French drugmaker Sanofi-Aventis.
The market for blood cancer treatment is heating up. And that could result in a David versus Goliath face-off, or a potentially potent partnership.
GlaxoSmithKline announced the results of the biggest-ever study of a cancer vaccine Wednesday, in the hopes of bolstering the competitive strength of its Cervarix against Merck's Gardasil.
Pfizer Inc. said on Wednesday it has discontinued trials of an experimental lung cancer drug licensed from Coley Pharmaceutical Group after an independent review committee deemed it ineffective, spurring a 60 percent decline in Coley shares.
Health regulators granted priority review for Bristol-Myers Squibb Co.'s experimental breast cancer drug ixabepilone, and an approval decision on the medicine could come by late October, the company said on Tuesday.
What's scarier than mad cow disease? Nothing, really -- except illnesses that are 10 billion times more likely to hurt you. Think about it this way: Your risk of getting mad cow is much lower than your odds of winning the Powerball lottery. In short, it's not likely to happen. What could happen? In her lifetime, the average woman has a 1 in 2 chance of developing osteoporosis and a 1 in 3 chance of heart disease.
For the first time, doctors said Monday they have found a pill that improves survival for people with liver cancer, a notoriously hard to treat disease diagnosed in more than half a million people globally each year
Republican Sen. Craig Thomas of Wyoming, who had been battling leukemia since November, died Monday night at the National Naval Medical Center in Bethesda, Maryland, a family spokesperson told CNN. He was 74.
CEOs reveal the business strategies that put companies like Akamai, Netflix, and Priceline at the top of Business 2.0's ranking of the 100 fastest-growing technology companies.
It started with a pain behind the nipple. Within a few weeks, a lump started to grow. It got bigger and more painful until a doctor finally diagnosed stage 4 breast cancer. It's a story shared by thousands around the United States, only in this case, the patient's name is Bill Morley.
A genetic mutation that raises the risk of breast cancer is found in up to 60 percent of U.S. women, making it the first truly common breast cancer susceptibility gene, researchers report.
More than thirty years after President Nixon vowed to win the war on cancer, the battle rages on with no victor in sight. But that won't stop Big Pharma and biotechs alike from trying to entice investors next week with fresh reports on the hunt for a panacea.
The drugmakers Merck, Schering-Plough and Wyeth all reported strong first-quarter earnings - with Schering and Wyeth trouncing forecasts - but investor reaction was mixed.
Scientists have unlocked the genetic code that could pave the way to a new generation of highly effective cancer drugs with none of the painful side effects of existing treatments.
ImClone Systems Inc. said Tuesday that a late-stage trial of its cancer drug Erbitux failed to extend survival in patients with pancreatic cancer, sending its shares down more than 7.5 percent.
Stalled sales, failed drug experiments and an SEC inquiry are among the problems nagging at Amgen and Genentech as the world's two biggest biotech companies get set to report first-quarter earnings.
Dendreon's stock price surged immediately after the open of Friday trading, following an surprise positive vote from FDA advisors the day before, which favored the experimental prostate cancer treatment Provenge.
GlaxoSmithKline said it submitted an application for its cervical cancer vaccine Cervarix to the Food and Drug Administration, bringing it one step closer to challenging Merck's now-dominant Gardasil.
Provenge, an experimental prostate cancer treatment from the drug company Dendreon, could have a rough time winning over Food and Drug Administration advisors on Thursday, analysts say.
The American Cancer Society is recommending MRIs in addition to mammograms for certain women considered to be at unusually high risk for breast cancer. Here are more details:
Doctors have removed a small, malignant growth from presidential spokesman Tony Snow's abdomen, but they determined the cancer had spread to his liver, the White House said Tuesday.
The biotech ImClone's stock price surged Friday following some bad news about its competitor Amgen's cancer drug Vectibix.
In light of Elizabeth Edwards' recurrent breast cancer, CNN Medical News producer Shahreen Abedin spoke with Dr. Rache Simmons, breast surgeon at the New York-Presbyterian Weill-Cornell Medical Center's Breast Cancer Center. Dr. Simmons has never treated Elizabeth Edwards, so the answers she gives are mainly about metastatic breast cancer in general, unless otherwise specified.
Elizabeth and John Edwards on Thursday described her cancer recurrence as a chronic condition that she'll have the rest of her life.
GlaxoSmithKline is getting closer to launching its challenge against Merck's monopoly on cervical cancer vaccines.
The Food and Drug Administration approved GlaxoSmithKline's breast cancer drug Tykerb, the drug company said Tuesday.
The Food and Drug Administration is expected to approve a breast cancer treatment from GlaxoSmithKline on Tuesday, analysts say.
Every few months, it seems, another wistful suitor pays a visit to the Raleigh offices of Robin Smith, founder and president of Biologics. Sometimes it's a rival, hoping to buy her out. Sometimes i...
The FDA's decision to grant over-the-counter status to GlaxoSmithKline's weight loss drug Alli could have big implications on national health, but the drug is not a miracle cure, experts said.
Nancy Brinker said that her sister might not have foreseen her legacy, but she knew Brinker would tackle breast cancer head on.
Genentech will unveil new details this weekend on tests of Avastin, one of its biggest-selling medicines, as it seeks to find new markets for the cancer drug.
The British drugmaker GlaxoSmithKline fired a shot over Merck's bow on Thursday, by launching a study comparing its own experimental vaccine for cervical cancer to Merck's Gardasil.
CNN.com readers are sharing their stories of sickness and survival in response to a commentary written by cycling great and cancer survivor, Lance Armstrong.
CNN.com readers shared powerful stories of sickness and survival in response to a commentary written by Lance Armstrong, one of cycling's all-time greats and possibly the world's best known cancer survivor.
There's plenty of fear about cancer, but a new American Cancer Society poll found more than a third of Americans surveyed -- 36 percent -- believe they have little or no control over reducing their risk for getting the disease.
Every Valentine's Day, I begin to sweat, my heart races and my palms turn cold as I think about the horrible, shocking moment when I was told I had cancer.
New study results could broaden the use of colon cancer drug Erbitux, but analysts have mixed opinions as to whether this means a boost in sales and royalties for ImClone and Bristol-Myers Squibb.
I'm not known for my patience. Patience is a polite quality and often appropriate, but it rarely gets things done. Impatience, however, is the hunger for results and intolerance for excuses and delays. Impatience got me over countless mountain passes, across the finish line in New York City and through four rounds of ruthless chemotherapy 10 years ago.
Strange as it may seem, much of our failure in fighting cancer--and more important, much of the potential for finally winning this fight--has to do with a definition. Some 2,400 years ago the Greek physician Hippocrates described cancer as a disease that spread out and grabbed on to another part of the body like "the arms of a crab," as he elegantly put it. Similarly, medical textbooks today say cancer begins when the cells of an expanding tumor push through the thin protein "basement" membrane that separates them from another tissue. It's a fancy way of saying that to be cancer, a malignant cell has to invade another part of the body.
Scientists said on Thursday that an experimental drug from GlaxoSmithKline to treat late-stage breast cancer has also shown promise in treating early stages of the disease.
The number of new breast cancer cases dropped by 7 percent in 2003, according to research presented at a breast cancer conference in San Antonio, Texas, on Thursday. But some cancer experts wonder whether the decline will last. CNN's Soledad O'Brien discussed the new findings with Chief Medical Correspondent Dr. Sanjay Gupta.
In the American Cancer Society's new lifestyle guidelines for cancer survivors, maintaining a healthy weight is at the top of the list. The cancer society recommends 30 minutes of exercise a day, at least five days a week and eating a diet that includes a lot of fruits and vegetables, whole grains and lean meat.
Celgene, the drug company that's cornered the market for blood cancer treatment, continues to wow investors with its constantly climbing stock price, and analysts expect the good times to keep rolling.
On the site of a former amusement park in a small Pennsylvania town, technicians sheathed in plastic suits labor over stainless steel fermentation tanks that look like brewery vats.
"What use could this company make of an electrical toy?"
It's called a gantry, and it's downright eerie. An assemblage of steel and cables mounted some 16 feet above the floor of a concrete chamber, it's more than 30 feet in length and width, with ends bracketed by 17-foot steel wheels resting on double rollers. The gantry weighs 190 tons, about as much as a diesel locomotive, but when it begins to revolve there is neither creak nor hum. As it rolls counterclockwise a bit past the halfway point, stops, returns to center, and then rotates the other way, it could be a "Star Wars" battle cruiser maneuvering soundlessly in space.
As Breast Cancer Awareness Month draws to a close, CNN.com asked readers to share their stories. Here is a sampling of responses, some of which have been edited:
Hey Big Pharma, listen up: this is NOT the time to be dropping the ball on a blockbuster.
Anyone who's had a loved one die of lung cancer has probably asked, why isn't there a way to screen for that disease? Especially as National Breast Cancer Awareness Month winds down, millions of Americans have been reminded that mammograms save lives. If it works for breast cancer, why can't something like that be done for the No. 1 cancer killer?
Merck & Co. reported reduced earnings, but still managed to edge past Wall Street expectations, even though Vioxx-related lawsuits against the company continue to mount.
A small, Colorado-based biotech could be the next big winner in the booming cancer drug industry, especially with a recent boost from the FDA, but that depends on the outcome of its risky drug trials.
This summer retired computer consultant Carleton Neville went online, took out his credit card, and ordered a $500 colon cancer test from DNA Direct, a San Francisco genetic-testing service.
Sandra Mahncke thought she was coming down with the flu in late April, but instead of a quick recovery, she has spent the last five months in a race for her life.
Wyeth filed with the FDA an application for an experimental drug that would extend the life of terminally ill kidney cancer patients, the company said Friday.
Earlier this year, rock singer Sheryl Crow underwent minimally invasive surgery for breast cancer.
| Most Viewed | Most Emailed | Top Searches |
| Most Viewed | Most Emailed | Top Searches |
Video
Photos
